Mary Duro

569 total citations
19 papers, 226 citations indexed

About

Mary Duro is a scholar working on Infectious Diseases, Oncology and Nutrition and Dietetics. According to data from OpenAlex, Mary Duro has authored 19 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Oncology and 4 papers in Nutrition and Dietetics. Recurrent topics in Mary Duro's work include HIV-related health complications and treatments (4 papers), HIV Research and Treatment (3 papers) and Trace Elements in Health (3 papers). Mary Duro is often cited by papers focused on HIV-related health complications and treatments (4 papers), HIV Research and Treatment (3 papers) and Trace Elements in Health (3 papers). Mary Duro collaborates with scholars based in Portugal, Italy and Poland. Mary Duro's co-authors include Edgar Pinto, Agostinho Almeida, Rui Medeiros, Jorge Polónia, João Pedro Ferreira, João Maldonado, José Alberto Silva, Susana Bertoquini, Rui Ramos and Luís Martins and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Nutrients.

In The Last Decade

Mary Duro

19 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Duro Portugal 9 69 42 41 39 30 19 226
Betelihem Terefe Ethiopia 10 66 1.0× 52 1.2× 24 0.6× 10 0.3× 20 0.7× 14 337
Larry Chan United States 7 23 0.3× 24 0.6× 74 1.8× 25 0.6× 15 0.5× 7 316
John Ayodele Olaniyi Nigeria 11 40 0.6× 15 0.4× 22 0.5× 12 0.3× 39 1.3× 31 246
Xiulan Lu China 10 14 0.2× 21 0.5× 19 0.5× 19 0.5× 30 1.0× 47 264
Adam S. Brinkman United States 13 31 0.4× 10 0.2× 45 1.1× 25 0.6× 40 1.3× 17 387
Benjamin E. Szpila United States 7 27 0.4× 29 0.7× 23 0.6× 18 0.5× 26 0.9× 7 402
Stephen Boyce United Kingdom 10 27 0.4× 10 0.2× 138 3.4× 46 1.2× 19 0.6× 18 311
B. Erbay Türkiye 11 45 0.7× 42 1.0× 22 0.5× 87 2.2× 6 0.2× 20 401
Şahin Takçı Türkiye 8 34 0.5× 37 0.9× 9 0.2× 18 0.5× 4 0.1× 41 268
Tea Štimac Croatia 8 24 0.3× 65 1.5× 69 1.7× 8 0.2× 15 0.5× 18 285

Countries citing papers authored by Mary Duro

Since Specialization
Citations

This map shows the geographic impact of Mary Duro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Duro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Duro more than expected).

Fields of papers citing papers by Mary Duro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Duro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Duro. The network helps show where Mary Duro may publish in the future.

Co-authorship network of co-authors of Mary Duro

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Duro. A scholar is included among the top collaborators of Mary Duro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Duro. Mary Duro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Estevinho, María Manuela, José Manuel Cabeda, Elisabete Machado, et al.. (2023). Viable Mycobacterium avium subsp. paratuberculosis Colonizes Peripheral Blood of Inflammatory Bowel Disease Patients. Microorganisms. 11(6). 1520–1520. 7 indexed citations
2.
3.
Duro, Mary, et al.. (2023). Further Evidence on Trace Element Imbalances in Haemodialysis Patients—Paired Analysis of Blood and Serum Samples. Nutrients. 15(8). 1912–1912. 8 indexed citations
4.
Bego, Tamer, Besim Prnjavorac, Damir Marjanović, et al.. (2022). Association of trace element status in COVID-19 patients with disease severity. Journal of Trace Elements in Medicine and Biology. 74. 127055–127055. 11 indexed citations
5.
Duro, Mary, et al.. (2022). Immune response to COVID-19 vaccination in a population with and without a previous SARS-CoV-2 infection. Irish Journal of Medical Science (1971 -). 192(2). 731–739. 2 indexed citations
6.
Duro, Mary, et al.. (2021). Pre-vaccination immune response to COVID-19 in a population in Northeast Portugal. Irish Journal of Medical Science (1971 -). 191(5). 1951–1958. 1 indexed citations
7.
Almeida, Agostinho, et al.. (2020). Trace element imbalances in patients undergoing chronic hemodialysis therapy – Report of an observational study in a cohort of Portuguese patients. Journal of Trace Elements in Medicine and Biology. 62. 126580–126580. 20 indexed citations
8.
Duro, Mary, et al.. (2018). Metabolic syndrome in human immunodeficiency virus-infected patients. International Journal of STD & AIDS. 29(11). 1089–1097. 14 indexed citations
9.
Duro, Mary, et al.. (2016). Hyperhomocysteinemia in human immunodeficiency virus-infected patients.. Biomedical Research-tokyo. 27(2). 0. 1 indexed citations
10.
Duro, Mary, et al.. (2014). Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients. International Journal of STD & AIDS. 26(11). 796–802. 4 indexed citations
11.
Nazareth, Naïr, Fernando Magro, Jani Silva, et al.. (2014). Infliximab therapy increases the frequency of circulating CD16+ monocytes and modifies macrophage cytokine response to bacterial infection. Clinical & Experimental Immunology. 177(3). 703–711. 25 indexed citations
12.
Duro, Mary, et al.. (2013). Lipid profile changes by high activity anti-retroviral therapy. Clinical Biochemistry. 46(9). 740–744. 15 indexed citations
13.
Fagnani, Daniele, E. Menatti, Mary Duro, et al.. (2007). Cetuximab and irinotecan (CPT11) salvage treatment for colorectal cancer (CRC) in progression after two or more chemotherapy (CT) lines: The POLONORD Group experience. Journal of Clinical Oncology. 25(18_suppl). 14575–14575. 1 indexed citations
14.
Fagnani, Daniele, Riccardo Franchi, Camillo Porta, et al.. (2006). Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis. Annals of Oncology. 18(3). 551–555. 23 indexed citations
15.
Polónia, Jorge, João Maldonado, Rui Ramos, et al.. (2006). Estimation of salt intake by urinary sodium excretion in a Portuguese adult population and its relationship to arterial stiffness.. PubMed. 25(9). 801–17. 63 indexed citations
16.
Fagnani, Daniele, Riccardo Franchi, Camillo Porta, et al.. (2006). Antithrombotic prophylaxis (AP) and catether-related infections in cancer patients (pts) carrying central venous devices (CVD): An observational study. Journal of Clinical Oncology. 24(18_suppl). 18550–18550. 1 indexed citations
17.
Duro, Mary, et al.. (1999). [Nutrition and chronic liver disease].. PubMed. 14 Suppl 2. 62S–70S. 1 indexed citations
18.
Labianca, Roberto, Stefano Cascinu, L. Frontini, et al.. (1997). High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study. Annals of Oncology. 8(2). 169–174. 20 indexed citations
19.
Labianca, Roberto, Sandro Barni, G. Ambrosini, et al.. (1994). Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-α2b and folinic acid. The “GISCAD” experience. European Journal of Cancer. 30(11). 1611–1616. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Betelihem Terefe Breakdown of academic impact, for papers by Larry Chan Breakdown of academic impact, for papers by John Ayodele Olaniyi Breakdown of academic impact, for papers by Xiulan Lu Breakdown of academic impact, for papers by Adam S. Brinkman Breakdown of academic impact, for papers by Benjamin E. Szpila Breakdown of academic impact, for papers by Stephen Boyce Breakdown of academic impact, for papers by B. Erbay Breakdown of academic impact, for papers by Şahin Takçı Breakdown of academic impact, for papers by Tea Štimac
Rankless by CCL
2026